Regulatory Affairs Services Provider in Uzbekistan
Uzbekistan is rapidly emerging as a strategic pharmaceutical market in Central Asia, supported by healthcare reforms, increased government investment, and a strong dependence on imported medicinal products. At the same time, the regulatory framework is evolving, with tighter controls on product quality, structured evaluation pathways, and increasing alignment with international standards.
Market entry in Uzbekistan is not purely documentation driven. Success depends on how well submissions are localized, how efficiently regulatory interactions are managed, and how accurately companies align with country-specific administrative expectations.
DDReg delivers Regulatory Affairs Services in Uzbekistan, enabling pharmaceutical companies to navigate registration requirements, reduce approval delays, and maintain compliance across the product lifecycle.
Drug Regulatory Authority Framework in Uzbekistan
Pharmaceutical regulation in Uzbekistan is governed by the national regulatory system commonly referred to as the TMDA framework, which includes the Agency for the Development of the Pharmaceutical Industry and the State Center for Expertise and Standardization of Medicines, Medical Devices, and Medical Equipment.
These authorities oversee marketing authorization, product evaluation, import control, GMP compliance, pharmacovigilance, and post-market surveillance. While Uzbekistan is increasingly aligning with global regulatory standards, including those of the World Health Organization, the system retains distinct national requirements that must be addressed with precision during submissions.
Regulatory Affairs Services in Uzbekistan
DDReg provides Pharmaceutical Regulatory Affairs in Uzbekistan with a focus on execution, compliance, and submission quality within a transitioning regulatory environment.
Our services include:
- Regulatory strategy and market entry planning for Uzbekistan
- Product registration and marketing authorization support
- CTD dossier preparation, localization, and compliance review
- Dossier gap analysis aligned with TMDA expectations
- Submission planning and coordination with regulatory authorities
- Regulatory query management and response handling
- Import licensing and documentation support
- Local agent coordination and regulatory representation
- Lifecycle management including variations, renewals, and updates
- Labeling compliance (Uzbek/Russian requirements)
- Regulatory intelligence and policy tracking
Regulatory Affairs Process in Uzbekistan
All pharmaceutical products must obtain marketing authorization before they can be marketed in Uzbekistan.
The regulatory process typically involves:
- Submission of a CTD-format dossier (with localized administrative documents)
- Administrative and technical screening
- Evaluation of quality, safety, and efficacy data
- Laboratory testing of product samples (where required)
- GMP compliance verification
- Approval and issuance of registration certificate
Foreign manufacturers must appoint a local authorized representative to handle submissions, importation, and regulatory communication.
In practice, timelines are influenced by:
- Dossier completeness and translation accuracy
- Laboratory testing requirements
- Administrative review cycles
A structured submission and proactive query management are critical to maintaining timelines.
Why Choose DDReg for Regulatory Affairs Services in Uzbekistan ?
DDReg approaches Regulatory Affairs Consulting in Uzbekistan with a strong focus on execution detail and regulatory accuracy. Our team brings experience in navigating evolving regulatory frameworks and managing administrative complexities that often delay approvals.
We ensure precise dossier localization, structured submission planning, and efficient handling of authority queries. By coordinating closely with local representatives and maintaining regulatory oversight throughout the lifecycle, DDReg helps companies move from submission to approval with fewer disruptions.
Global Reach Explorer
Find Your Solution
Our Regulatory Affairs Consulting Services in Uzbekistan portfolio covers:
Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...
New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...
Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...
Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...
API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...
CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...
Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...
Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...
ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.
Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...
